Up at 5AM: The 5AM Solutions Blog

Taking Pharma to Where the Patients Are

Posted on Tue, Jul 08, 2014 @ 11:00 AM

According to Murray Aitken, Executive Director of the IMS Institute for Healthcare Informaticstwitter 512 “Social media is where the patients are.” 

However, there is a disconnect. While individuals — including patients — have eagerly embraced social media to share information about drugs, therapies, and medical devices, drug and device makers themselves have been slow to embrace social networking. 

At the beginning of 2014, only half of the 50 biggest pharmaceutical companies regularly engage with the public using social media. 

Chief among the pharmaceutical and device makers’ concerns has been a relative silence from regulatory agencies on how (or whether) companies should use social networking to communicate accurate, up-to-date information about their products. 

 In response, the FDA has released draft guidance to industry on using social media. MobiHealthNews recently published a good summation of the document:  8 Takeaways from the FDA’s Draft Guidance on Social Media

We’ve published previous blog posts on social media’s impact here. You can download the IMS Institute’s report, Engaging Patients Through Social Media here. Murray Aitken's video introduction to the report is below.


Tags: FDA, social media, pharma


Diagnostic Tests on the Map of Biomedicine


Download the ebook based on our popular blog series. This free, 50+ page edition features updated, expanded posts and redesigned, easier-to-read maps. 

FREE Biobanking Ebook

Biobanking Free Ebook
Get this 29 page PDF document on how data science can be used to advance biorepositories.

 Free NGS Whitepaper

NGS White Paper for Molecular Diagnostics

Learn about the applications, opportunities and challenges in this updated free white paper. 

Recent Posts